{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:59:09Z","timestamp":1765609149971,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Mayo Clinic Center for Biomedical Discovery"},{"name":"Mayo Clinic Department of OB\/GYN"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s43032-024-01775-6","type":"journal-article","created":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T17:37:20Z","timestamp":1735493840000},"page":"417-427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the In Vivo Efficacy of the JAK Inhibitor AZD1480 in Uterine Leiomyomas Using a Patient-derived Xenograft Murine Model"],"prefix":"10.1007","volume":"32","author":[{"suffix":"II","given":"Michael F.","family":"Neblett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merrick T.","family":"Ducharme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Meridew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Haak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Girard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Tschumperlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1110-2400","authenticated-orcid":false,"given":"Elizabeth A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,29]]},"reference":[{"issue":"3","key":"1775_CR1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/molehr\/gat083","volume":"20","author":"SJ Holdsworth-Carson","year":"2014","unstructured":"Holdsworth-Carson SJ, et al. Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues. Mol Hum Reprod. 2014;20(3):250\u20139.","journal-title":"Mol Hum Reprod"},{"issue":"7","key":"1775_CR2","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/en.2018-00151","volume":"159","author":"MFB Jamaluddin","year":"2018","unstructured":"Jamaluddin MFB, Nahar P, Tanwar PS. Proteomic characterization of the extracellular matrix of human uterine fibroids. Endocrinology. 2018;159(7):2656\u201369.","journal-title":"Endocrinology"},{"issue":"1","key":"1775_CR3","first-page":"16","volume":"37","author":"EA Stewart","year":"2022","unstructured":"Stewart EA, Nowak RA. Uterine fibroids: hiding in plain sight. Physiology (Bethesda). 2022;37(1):16\u201327.","journal-title":"Physiology (Bethesda)"},{"issue":"4","key":"1775_CR4","doi-asserted-by":"crossref","first-page":"474.e1","DOI":"10.1016\/j.ajog.2007.11.057","volume":"198","author":"R Rogers","year":"2008","unstructured":"Rogers R, et al. Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol. 2008;198(4):474.e1-11.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1775_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/humupd\/dmx032","volume":"24","author":"MS Islam","year":"2018","unstructured":"Islam MS, et al. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018;24(1):59\u201385.","journal-title":"Hum Reprod Update"},{"issue":"11","key":"1775_CR6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/jwh.2018.7076","volume":"27","author":"EE Marsh","year":"2018","unstructured":"Marsh EE, et al. Burden, prevalence, and treatment of uterine fibroids: a survey of U.S. women. J Womens Health (Larchmt). 2018;27(11):1359\u201367.","journal-title":"J Womens Health (Larchmt)"},{"issue":"10","key":"1775_CR7","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","volume":"124","author":"EA Stewart","year":"2017","unstructured":"Stewart EA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501\u201312.","journal-title":"BJOG"},{"issue":"4","key":"1775_CR8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ajog.2006.02.020","volume":"195","author":"M Flynn","year":"2006","unstructured":"Flynn M, et al. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006;195(4):955\u201364.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1775_CR9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/GME.0000000000001043","volume":"25","author":"SK Laughlin-Tommaso","year":"2018","unstructured":"Laughlin-Tommaso SK, et al. Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause. 2018;25(5):483\u201392.","journal-title":"Menopause"},{"issue":"1","key":"1775_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/GME.0000000000001415","volume":"27","author":"SK Laughlin-Tommaso","year":"2020","unstructured":"Laughlin-Tommaso SK, et al. Long-term risk of de novo mental health conditions after hysterectomy with ovarian conservation: a cohort study. Menopause. 2020;27(1):33\u201342.","journal-title":"Menopause"},{"issue":"2","key":"1775_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/GME.0000000000000506","volume":"23","author":"SK Laughlin-Tommaso","year":"2016","unstructured":"Laughlin-Tommaso SK, et al. Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation. Menopause. 2016;23(2):121\u20138.","journal-title":"Menopause"},{"issue":"5","key":"1775_CR12","doi-asserted-by":"crossref","first-page":"723.e1","DOI":"10.1016\/j.ajog.2020.04.037","volume":"223","author":"KM Tuesley","year":"2020","unstructured":"Tuesley KM, et al. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality. Am J Obstet Gynecol. 2020;223(5):723.e1-723.e16.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"1775_CR13","first-page":"747","volume":"32","author":"LV Farland","year":"2023","unstructured":"Farland LV, et al. Hysterectomy with and without oophorectomy, tubal ligation, and risk of cardiovascular disease in the nurses\u2019 health study II. J Womens Health (Larchmt). 2023;32(7):747\u201356.","journal-title":"J Womens Health (Larchmt)"},{"key":"1775_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bpobgyn.2015.11.015","volume":"34","author":"FM Reis","year":"2016","unstructured":"Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:13\u201324.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5332","key":"1775_CR15","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","volume":"277","author":"JE Darnell Jr","year":"1997","unstructured":"Darnell JE Jr. STATs and gene regulation. Science. 1997;277(5332):1630\u20135.","journal-title":"Science"},{"issue":"3","key":"1775_CR16","doi-asserted-by":"crossref","first-page":"a011205","DOI":"10.1101\/cshperspect.a011205","volume":"4","author":"DA Harrison","year":"2012","unstructured":"Harrison DA. The Jak\/STAT pathway. Cold Spring Harb Perspect Biol. 2012;4(3):a011205.","journal-title":"Cold Spring Harb Perspect Biol."},{"issue":"1","key":"1775_CR17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/biom13010119","volume":"13","author":"J Liu","year":"2023","unstructured":"Liu J, Wang F, Luo F. The Role of JAK\/STAT pathway in fibrotic diseases: molecular and cellular mechanisms. Biomolecules. 2023;13(1):119.","journal-title":"Biomolecules"},{"issue":"3","key":"1775_CR18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bjc.2015.233","volume":"113","author":"SJ Thomas","year":"2015","unstructured":"Thomas SJ, et al. The role of JAK\/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer. 2015;113(3):365\u201371.","journal-title":"Br J Cancer"},{"issue":"2","key":"1775_CR19","first-page":"206","volume":"1","author":"M Malik","year":"2020","unstructured":"Malik M, et al. Cross-talk between Janus kinase-signal transducer and activator of transcription pathway and transforming growth factor beta pathways and increased collagen1A1 production in uterine leiomyoma cells. F S Sci. 2020;1(2):206\u201320.","journal-title":"F S Sci"},{"issue":"3","key":"1775_CR20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.18632\/aging.203873","volume":"14","author":"D Huang","year":"2022","unstructured":"Huang D, et al. Inhibiting effect of miR-29 on proliferation and migration of uterine leiomyoma via the STAT3 signaling pathway. Aging (Albany NY). 2022;14(3):1307\u201320.","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"1775_CR21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1634\/theoncologist.2013-0198","volume":"18","author":"ER Plimack","year":"2013","unstructured":"Plimack ER, et al. AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors. Oncologist. 2013;18(7):819\u201320.","journal-title":"Oncologist"},{"issue":"6","key":"1775_CR22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccr.2009.10.015","volume":"16","author":"M Hedvat","year":"2009","unstructured":"Hedvat M, et al. The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors. Cancer Cell. 2009;16(6):487\u201397.","journal-title":"Cancer Cell"},{"issue":"2","key":"1775_CR23","doi-asserted-by":"crossref","first-page":"156.e1","DOI":"10.1016\/j.ajog.2008.02.010","volume":"199","author":"MH Hassan","year":"2008","unstructured":"Hassan MH, et al. Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice. Am J Obstet Gynecol. 2008;199(2):156.e1-8.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1775_CR24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1620\/tjem.222.55","volume":"222","author":"K Tsuiji","year":"2010","unstructured":"Tsuiji K, et al. Establishment of a novel xenograft model for human uterine leiomyoma in immunodeficient mice. Tohoku J Exp Med. 2010;222(1):55\u201361.","journal-title":"Tohoku J Exp Med"},{"issue":"11","key":"1775_CR25","doi-asserted-by":"crossref","first-page":"e0142429","DOI":"10.1371\/journal.pone.0142429","volume":"10","author":"M Fritsch","year":"2015","unstructured":"Fritsch M, et al. Application of a patient derived xenograft model for predicative study of uterine fibroid disease. PLoS One. 2015;10(11):e0142429.","journal-title":"PLoS One"},{"issue":"2","key":"1775_CR26","doi-asserted-by":"crossref","first-page":"196.e1","DOI":"10.1016\/j.ajog.2015.03.055","volume":"213","author":"MA Borahay","year":"2015","unstructured":"Borahay MA, et al. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study. Am J Obstet Gynecol. 2015;213(2):196.e1-8.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1775_CR27","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1038\/s41598-018-27138-1","volume":"8","author":"Y Suzuki","year":"2018","unstructured":"Suzuki Y, et al. Establishment of a novel mouse xenograft model of human uterine leiomyoma. Sci Rep. 2018;8(1):8872.","journal-title":"Sci Rep"},{"issue":"6","key":"1775_CR28","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s43032-019-00123-3","volume":"27","author":"M Malik","year":"2020","unstructured":"Malik M, Britten J, Catherino WH. Development and validation of hormonal impact of a mouse xenograft model for human uterine leiomyoma. Reprod Sci. 2020;27(6):1304\u201317.","journal-title":"Reprod Sci"},{"issue":"1","key":"1775_CR29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.fertnstert.2019.09.018","volume":"113","author":"A Corach\u00e1n","year":"2020","unstructured":"Corach\u00e1n A, et al. Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model. Fertil Steril. 2020;113(1):205-216.e4.","journal-title":"Fertil Steril"},{"issue":"11","key":"1775_CR30","doi-asserted-by":"crossref","first-page":"e0142190","DOI":"10.1371\/journal.pone.0142190","volume":"10","author":"J S\u00e1pi","year":"2015","unstructured":"S\u00e1pi J, et al. Tumor volume estimation and quasi-continuous administration for most effective bevacizumab therapy. PLoS One. 2015;10(11):e0142190.","journal-title":"PLoS One"},{"issue":"12","key":"1775_CR31","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1158\/1535-7163.MCT-11-0480","volume":"10","author":"BC McFarland","year":"2011","unstructured":"McFarland BC, et al. Therapeutic potential of AZD1480 for the treatment of human glioblastoma. Mol Cancer Ther. 2011;10(12):2384\u201393.","journal-title":"Mol Cancer Ther"},{"issue":"21","key":"1775_CR32","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1158\/0008-5472.CAN-11-1217","volume":"71","author":"H Xin","year":"2011","unstructured":"Xin H, et al. Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480. Cancer Res. 2011;71(21):6601\u201310.","journal-title":"Cancer Res"},{"issue":"4","key":"1775_CR33","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1158\/1535-7163.MCT-14-0800","volume":"14","author":"G Gritsina","year":"2015","unstructured":"Gritsina G, et al. Targeted Blockade of JAK\/STAT3 signaling inhibits ovarian carcinoma growth. Mol Cancer Ther. 2015;14(4):1035\u201347.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"1775_CR34","first-page":"805","volume":"55","author":"CP Jones","year":"2016","unstructured":"Jones CP, Boyd KL, Wallace JM. Evaluation of mice undergoing serial oral gavage while awake or anesthetized. J Am Assoc Lab Anim Sci. 2016;55(6):805\u201310.","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"4","key":"1775_CR35","doi-asserted-by":"crossref","first-page":"e0215646","DOI":"10.1371\/journal.pone.0215646","volume":"14","author":"FL Jayes","year":"2019","unstructured":"Jayes FL, et al. Evidence of biomechanical and collagen heterogeneity in uterine fibroids. PLoS One. 2019;14(4):e0215646.","journal-title":"PLoS One"},{"issue":"2","key":"1775_CR36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41568-018-0090-8","volume":"19","author":"J Huynh","year":"2019","unstructured":"Huynh J, et al. Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map. Nat Rev Cancer. 2019;19(2):82\u201396.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1775_CR37","first-page":"219","volume":"2","author":"JL Britten","year":"2021","unstructured":"Britten JL, et al. Three-dimensional human leiomyoma xenografts induce angiogenesis by inducing hypoxia inducible factor-1 alpha. F S Sci. 2021;2(2):219\u201327.","journal-title":"F S Sci"},{"issue":"5","key":"1775_CR38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/GCO.0000000000000650","volume":"32","author":"E Cetin","year":"2020","unstructured":"Cetin E, Al-Hendy A, Ciebiera M. Non-hormonal mediators of uterine fibroid growth. Curr Opin Obstet Gynecol. 2020;32(5):361\u201370.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"50","key":"1775_CR39","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","volume":"105","author":"SD Peddada","year":"2008","unstructured":"Peddada SD, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A. 2008;105(50):19887\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1775_CR40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.18632\/oncotarget.930","volume":"4","author":"S Yan","year":"2013","unstructured":"Yan S, Li Z, Thiele CJ. Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo. Oncotarget. 2013;4(3):433\u201345.","journal-title":"Oncotarget"},{"issue":"10","key":"1775_CR41","doi-asserted-by":"crossref","first-page":"e46869","DOI":"10.1371\/journal.pone.0046869","volume":"7","author":"JP Couto","year":"2012","unstructured":"Couto JP, et al. AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines. PLoS One. 2012;7(10):e46869.","journal-title":"PLoS One"},{"issue":"11","key":"1775_CR42","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9(11):798\u2013809.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"1775_CR43","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/pbc.25175","volume":"61","author":"PJ Houghton","year":"2014","unstructured":"Houghton PJ, et al. Initial solid tumor testing (stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing program. Pediatr Blood Cancer. 2014;61(11):1972\u20139.","journal-title":"Pediatr Blood Cancer"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-024-01775-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-024-01775-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-024-01775-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T18:39:10Z","timestamp":1739471950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-024-01775-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,29]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1775"],"URL":"https:\/\/doi.org\/10.1007\/s43032-024-01775-6","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"type":"print","value":"1933-7191"},{"type":"electronic","value":"1933-7205"}],"subject":[],"published":{"date-parts":[[2024,12,29]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EAS has received grants for her institution from the Agency for Healthcare Research and Quality\/Patient-Centered Outcome Research (P50HS23418), and the Eunice Kennedy Shriver Institute of Child Health and Human Development of the National Institutes of Health (R01HD105714, R01HD109127-01A1 and P50HD115283); has received consulting fees from AbbVie, Anylyn; support for service on a DSMB from Myovant, holds a patent for Methods and Compounds for Treatment of Abnormal Uterine Bleeding; has received royalties from UpToDate; has received fees for developing educational content from the MED-IQ, Physicians\u2019 Education Resource, Omnia Education, Omnicuris and WebMD; and serves as an unpaid advisor to The Fibroid Foundation and the unpaid treasurer of the International Gynecologic Society. The remaining authors report no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}